Sedana Medical AB (FRA:7D2A) Cyclically Adjusted Revenue per Share: €0.12 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7D2A Sedana Medical AB FRA:7D2A
69 GF Score
Price €0.86
GF Value €1.47
! 2 Warning Signs
View Full Analysis

What is Sedana Medical AB Cyclically Adjusted Revenue per Share?

Sedana Medical AB FRA:7D2A +3.63% 69 Cyclically Adjusted Revenue per Share is €0.12 as of Jun. 2026. GuruFocus rates FRA:7D2A with a GF Score™ of 69/100 and a GF Value™ of €1.47. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sedana Medical AB's adjusted revenue per share for the three months ended in Jun. 2026 was €0.045. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.12 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-02), Sedana Medical AB's current stock price is €0.857. Sedana Medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €0.12. Sedana Medical AB's Cyclically Adjusted PS Ratio of today is 7.14.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Sedana Medical AB was 9.21. The lowest was 5.60. And the median was 6.78.


Sedana Medical AB  (FRA:7D2A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sedana Medical AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.857/0.12
=7.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Sedana Medical AB was 9.21. The lowest was 5.60. And the median was 6.78.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sedana Medical AB Cyclically Adjusted Revenue per Share Related Terms


Sedana Medical AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sedana Medical AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB Cyclically Adjusted Revenue per Share Chart

Sedana Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.12

Sedana Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.12 0.12 0.12 0.12

FRA:7D2A vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Sedana Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sedana Medical AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sedana Medical AB's Cyclically Adjusted PS Ratio falls into.


FRA:7D2A
69GF Score
Sedana Medical AB FRA:7D2A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sedana Medical AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sedana Medical AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.045/134.6100*134.6100
=0.045

Current CPI (Jun. 2026) = 134.6100.

Sedana Medical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.012 101.138 0.016
201612 0.013 102.022 0.017
201703 0.015 102.022 0.020
201706 0.015 102.752 0.020
201709 0.015 103.279 0.020
201712 0.016 103.793 0.021
201803 0.021 103.962 0.027
201806 0.018 104.875 0.023
201809 0.015 105.679 0.019
201812 0.019 105.912 0.024
201903 0.021 105.886 0.027
201906 0.020 106.742 0.025
201909 0.019 107.214 0.024
201912 0.018 107.766 0.022
202003 0.034 106.563 0.043
202006 0.042 107.498 0.053
202009 0.022 107.635 0.028
202012 0.049 108.296 0.061
202103 0.048 108.360 0.060
202106 0.041 108.928 0.051
202109 0.030 110.338 0.037
202112 0.048 112.486 0.057
202203 0.032 114.825 0.038
202206 0.025 118.384 0.028
202209 0.025 122.296 0.028
202212 0.033 126.365 0.035
202303 0.034 127.042 0.036
202306 0.032 129.407 0.033
202309 0.029 130.224 0.030
202312 0.040 131.912 0.041
202403 0.043 132.205 0.044
202406 0.037 132.716 0.038
202409 0.035 132.304 0.036
202412 0.043 132.987 0.044
202503 0.053 132.825 0.054
202506 0.045 133.699 0.045
202509 0.038 133.480 0.038
202512 0.048 133.390 0.048
202603 0.050 133.560 0.050
202606 0.045 134.610 0.045

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.12 mean?
Sedana Medical AB (FRA:7D2A) has a Cyclically Adjusted Revenue per Share of €0.12 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sedana Medical AB and its competitors.
Is Sedana Medical AB's Cyclically Adjusted Revenue per Share too high?
Sedana Medical AB's current Cyclically Adjusted Revenue per Share is €0.12. Overall, Sedana Medical AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Sedana Medical AB's Cyclically Adjusted Revenue per Share of €0.12 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sedana Medical AB and its competitors. Sedana Medical AB's current Cyclically Adjusted Revenue per Share is €0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Sedana Medical AB (FRA:7D2A) has a current Cyclically Adjusted Revenue per Share of €0.12. The stock's GF Value™ is €1.47, compared to a current price of €0.86 — trading 41.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.12. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sedana Medical AB (FRA:7D2A), the current Cyclically Adjusted Revenue per Share is €0.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sedana Medical AB (FRA:7D2A) Overvalued in 2026?

Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued. The current stock price of €0.86 is trading 41.7% below its estimated GF Value™ of €1.47.

Key valuation signals for FRA:7D2A:

  • Cyclically Adjusted Revenue per Share: €0.12
  • GF Value™: €1.47 vs. price of €0.86 (41.7% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the FRA:7D2A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sedana Medical AB Business Description

Other Exchanges SEDANA:Sweden
Address Svardvagen 3A, Danderyd, SWE, SE-182 33
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score

Get the complete analysis for FRA:7D2A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€1.47
GF Value